Skip to content

Benefits of the HiResolutionTM Bionic Ear System in Adults With Low-Frequency Hearing

Benefits of the HiResolutionTM Bionic Ear System in Adults With Low-Frequency Hearing.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01824563
Enrollment
30
Registered
2013-04-05
Start date
2013-06-30
Completion date
2017-08-31
Last updated
2018-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe-to-profound Hearing Loss

Brief summary

The goal of this investigation is to generate the needed PMCF data for the HiFocus Mid-Scala electrode. As a point of interest the investigators would like to evaluate the benefit to patients with low-frequency residual hearing implanted with the HiFocus Mid-Scala Electrode. The HiFocus Mid-Scala electrode array is designed to allow surgeons the flexibility to use a variety of contemporary surgical techniques that have been shown to enable easy insertion and to minimize cochlear trauma (see, e.g., Adunka and Buchman, 2007; Friedland and Runge-Samuelson, 2009; Roland et al., 2007). Temporal bone experiments have shown the HiFocus Mid-Scala electrode array to be straightforward to insert while causing minimal trauma to cochlear structures during and after surgery (Lenarz et al., 2010). In addition , the HiFocus Mid-Scala has already shown to be a safe electrode and promising post op clinical results in the premarketing study that is now in the final stage.

Interventions

OTHERObservational study

Sponsors

Advanced Bionics AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * Definite Postlingual onset of severe-to-profound hearing loss as documented by completing main stream primary education. * Local language proficiency * Bilateral, sensorineural hearing loss

Exclusion criteria

* Previous inner ear surgery or active middle ear pathology. * Cochlear malformation or obstruction * Presence of additional disabilities that would prevent or interfere with participation in the required study procedures * Medical or psychological conditions that contraindicate surgery or impact the ability to manage an implanted device or the study-related procedures * Evidence of central auditory lesion or compromised auditory nerve * Concurrent participation in other study

Design outcomes

Primary

MeasureTime frameDescription
CI aided word recognition scores in quiet and noise.12 months post activationCI aided word recognition scores in quiet and noise.

Other

MeasureTime frameDescription
Evaluate the potential of preservation of residual low frequency hearing12 monthsEvaluate the difference in Pure tone thresholds pre and post implantation in the low frequencies.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026